Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 656

1.

Glycated haemoglobin and cardiovascular outcomes in people with Type 2 diabetes: a large prospective cohort study.

Elley CR, Kenealy T, Robinson E, Drury PL.

Diabet Med. 2008 Nov;25(11):1295-301. doi: 10.1111/j.1464-5491.2008.02581.x.

PMID:
19046219
2.

An association between ethnicity and cardiovascular outcomes for people with Type 2 diabetes in New Zealand.

Kenealy T, Elley CR, Robinson E, Bramley D, Drury PL, Kerse NM, Moyes SA, Arroll B.

Diabet Med. 2008 Nov;25(11):1302-8. doi: 10.1111/j.1464-5491.2008.02593.x.

PMID:
19046220
3.

Independent association of HbA(1c) and incident cardiovascular disease in people without diabetes.

Adams RJ, Appleton SL, Hill CL, Wilson DH, Taylor AW, Chittleborough CR, Gill TK, Ruffin RE.

Obesity (Silver Spring). 2009 Mar;17(3):559-63. doi: 10.1038/oby.2008.592. Epub 2009 Jan 8.

4.

Investigation of cardiovascular risk factors in type 2 diabetes in a rural Australian Division of General Practice.

Wan Q, Taggart J, Harris MF, Jayasinghe UW, Ruscoe W, Snow J, Powell-Davies G.

Med J Aust. 2008 Jul 21;189(2):86-9.

PMID:
18637775
5.

Diabetic retinopathy is associated with an increased incidence of cardiovascular events in Type 2 diabetic patients.

Targher G, Bertolini L, Zenari L, Lippi G, Pichiri I, Zoppini G, Muggeo M, Arcaro G.

Diabet Med. 2008 Jan;25(1):45-50. doi: 10.1111/j.1464-5491.2007.02327.x.

PMID:
18199131
6.

Lipid but not glycaemic parameters predict total mortality from type 2 diabetes mellitus in Canterbury, New Zealand.

Florkowski CM, Scott RS, Moir CL, Graham PJ.

Diabet Med. 1998 May;15(5):386-92.

PMID:
9609360
7.

A prospective study of cardiovascular disease in patients with Type 2 diabetes. 6.3 years of follow-up.

Rius Riu F, Salinas Vert I, Lucas Martín A, Romero González R, Sanmartí Sala A.

J Diabetes Complications. 2003 Sep-Oct;17(5):235-42.

PMID:
12954150
8.

Relationship between mean blood glucose and glycated haemoglobin in Type 2 diabetic patients.

Makris K, Spanou L, Rambaouni-Antoneli A, Koniari K, Drakopoulos I, Rizos D, Haliassos A.

Diabet Med. 2008 Feb;25(2):174-8. doi: 10.1111/j.1464-5491.2007.02379.x.

PMID:
18290858
9.

Glycosylated hemoglobin and mortality in patients with nondiabetic chronic kidney disease.

Menon V, Greene T, Pereira AA, Wang X, Beck GJ, Kusek JW, Collins AJ, Levey AS, Sarnak MJ.

J Am Soc Nephrol. 2005 Nov;16(11):3411-7. Epub 2005 Oct 5.

10.

Glycaemic control and the risk of mortality in elderly type 2 diabetic patients (ZODIAC-20).

van Hateren KJ, Landman GW, Kleefstra N, Drion I, Groenier KH, Houweling ST, Bilo HJ.

Int J Clin Pract. 2011 Apr;65(4):415-9. doi: 10.1111/j.1742-1241.2010.02596.x.

PMID:
21401830
11.

Effect of tight control of HbA1c and blood pressure on cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR).

Cederholm J, Zethelius B, Nilsson PM, Eeg-Olofsson K, Eliasson B, Gudbjörnsdottir S; Swedish National Diabetes Register.

Diabetes Res Clin Pract. 2009 Oct;86(1):74-81. doi: 10.1016/j.diabres.2009.07.003. Epub 2009 Aug 12.

PMID:
19679369
12.

Triglyceride, albuminuria and blood pressure are the major associations of non-fatal cardiovascular disease in Chinese type 2 diabetes.

Ko GT, Chan JC, Chow CC, Yeung VT, Chan WB, So WY, Ma RC, Ozaki R, Cockram CS.

Acta Diabetol. 2003 Jun;40(2):80-4.

PMID:
12861405
13.

HbA(1c) levels in cardiovascular diseased patients without diabetes in a developing country.

Sharma TK, Parchwani H, Kaushik GG, Shankar V, Dahiya K, Ghalaut VS, Sharma N.

Clin Lab. 2011;57(7-8):517-22.

PMID:
21888015
14.

Association between HbA1c and cardiovascular disease mortality in older Hong Kong Chinese with diabetes.

Xu L, Chan WM, Hui YF, Lam TH.

Diabet Med. 2012 Mar;29(3):393-8. doi: 10.1111/j.1464-5491.2011.03456.x.

PMID:
21916977
15.
16.

The impact of Type 2 diabetes and microalbuminuria on future cardiovascular events in patients with clinically manifest vascular disease from the Second Manifestations of ARTerial disease (SMART) study.

Soedamah-Muthu SS, Visseren FL, Algra A, van der Graaf Y; SMART Study Group.

Diabet Med. 2008 Jan;25(1):51-7. doi: 10.1111/j.1464-5491.2007.02345.x.

PMID:
18199132
17.

Low incidence of cardiovascular events in Japanese patients with Type 2 diabetes in primary care settings: a prospective cohort study (JDDM 20).

Yokoyama H, Matsushima M, Kawai K, Hirao K, Oishi M, Sugimoto H, Takeda H, Minami M, Kobayashi M, Sone H; Japan Diabetes Clinical Data Management Study Group.

Diabet Med. 2011 Oct;28(10):1221-8. doi: 10.1111/j.1464-5491.2011.03347.x.

PMID:
21658121
18.

Glycaemic control, disease duration and beta-cell function in patients with Type 2 diabetes in a Swedish community. Skaraborg Hypertension and Diabetes Project.

Ostgren CJ, Lindblad U, Ranstam J, Melander A, Råstam L; Skaraborg hypertension and Diabetees Project.

Diabet Med. 2002 Feb;19(2):125-9.

PMID:
11874428
19.

Risk factors for cardiovascular mortality and morbidity: the WHO Mutinational Study of Vascular Disease in Diabetes.

Fuller JH, Stevens LK, Wang SL.

Diabetologia. 2001 Sep;44 Suppl 2:S54-64.

PMID:
11587051
20.

Supplemental Content

Support Center